Therefore, additional studies are warranted in order to define the contribution of Nrf2 to intestinal lipoprotein metabolism and cardiovascular diseases, especially in response to CFTR deficiency that affects the expression of Nrf2. This evidence concerns the gene NFE2L2 and cardiovascular disorder.